Abbott India

₹29169.4 115.8 | 0.4%

WEBSITE BSE:500488 NSE : ABBOTT (I) 09 Dec, 12:28

Market Cap ₹61983 Cr.

Stock P/E 51.6

P/B 17.6

Current Price ₹29169.4

Book Value ₹ 1657

Face Value 10

52W High ₹30499.9

Dividend Yield 1.41%

52W Low ₹ 21983.4

Edit Ratio

Abbott India Research see more...

Overview Inc. Year: 1944Industry: Pharmaceuticals & Drugs

Abbott India Ltd is a healthcare company engaged in pharmaceuticals enterprise. The Company has a portfolio of technology-based offerings in diagnostics, medical devices, nutritional and branded well-known pharmaceuticals. Its commercial enterprise operations are divided into four commercial enterprise divisions: Women's Health & Gastrointestinal, Gastroenterology and Hepatic Care; Speciality Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestinal, Gastroenterology and Hepatic Care division has a combination of internationaal and local brands present inside the pregnancy, constipation and liver diseases segments. The Speciality Care department includes various merchandise within the treatment of central nervous system and metabolic problems. The GenNext department focuses on several remedy areas, inclusive of pain management, nutrients and pregnancy. Its vaccines comprises Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present inside the over-the-counter antacid segment.

Abbott India Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Abbott India Quarterly Results

#(Fig in Cr.)	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Net Sales	1304	1379	1322	1343	1479	1494	1437	1439	1558	1633
Other Income	27	34	44	50	56	56	56	81	67	60
Total Income	1331	1413	1366	1393	1535	1550	1493	1520	1625	1693
Total Expenditure	1034	1036	1010	1063	1124	1113	1049	1109	1167	1194
Operating Profit	297	377	356	330	411	436	443	411	458	499
Interest	4	4	4	4	3	3	3	3	3	3
Depreciation	17	17	18	17	17	18	18	18	18	18
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	275	355	335	308	390	415	422	390	437	479
Provision for Tax	70	90	88	77	100	102	111	103	109	121
Profit After Tax	206	266	247	231	290	313	311	287	328	359
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	206	266	247	231	290	313	311	287	328	359
Adjusted Earnings Per Share	96.8	125	116.2	108.9	136.6	147.3	146.3	135.1	154.4	168.8

Abbott India Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	2276	2289	2615	2903	3299	3679	4093	4310	4913	5349	5849	6067
Other Income	49	48	51	60	118	114	115	83	83	154	248	264
Total Income	2325	2338	2666	2963	3417	3793	4208	4393	4997	5503	6097	6331
Total Expenditure	2009	1978	2251	2508	2775	3075	3337	3391	3832	4143	4396	4519
Operating Profit	317	360	415	455	641	718	871	1002	1165	1360	1701	1811
Interest	0	1	3	2	4	2	9	18	19	16	12	12
Depreciation	22	15	14	16	16	17	60	58	66	70	71	72
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	295	344	398	436	621	699	803	926	1080	1274	1618	1728
Provision for Tax	96	115	143	160	220	249	210	235	281	324	417	444
Profit After Tax	198	229	255	277	401	450	593	691	799	949	1201	1285
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	198	229	255	277	401	450	593	691	799	949	1201	1285
Adjusted Earnings Per Share	93.4	107.7	120.1	130.2	188.8	211.9	279	325	375.9	446.8	565.3	604.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	9%	11%	10%	10%
Operating Profit CAGR	25%	19%	19%	18%
PAT CAGR	27%	20%	22%	20%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	27%	16%	18%	24%
ROE Average	35%	32%	30%	28%
ROCE Average	47%	44%	41%	40%

Abbott India Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	788	938	1196	1387	1693	2009	2432	2602	2820	3189	3699
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	443	432	29	35	41	62	210	190	184	144	136
Total Current Liabilities	652	834	382	632	668	857	891	1031	1203	1206	1343
Total Liabilities	1883	2204	1607	2053	2402	2928	3532	3823	4207	4539	5178
Fixed Assets	98	96	108	110	81	105	270	251	271	237	225
Other Non-Current Assets	442	445	48	51	55	62	58	84	83	1277	1707
Total Current Assets	1343	1663	1451	1893	2231	2761	3205	3487	3853	3025	3246
Total Assets	1883	2204	1607	2053	2402	2928	3532	3823	4207	4539	5178

Abbott India Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	109	79	49	140	202	38	137	145	218	133	240
Cash Flow from Operating Activities	155	215	249	307	153	499	626	727	948	893	1213
Cash Flow from Investing Activities	-144	-187	-77	-155	-215	-257	-401	-72	-396	-148	-416
Cash Flow from Financing Activities	-42	-58	-80	-90	-102	-143	-217	-582	-637	-639	-745
Net Cash Inflow / Outflow	-31	-30	91	62	-165	99	8	73	-86	107	52
Closing Cash & Cash Equivalent	79	49	140	202	38	137	145	218	133	240	292

Abbott India Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	93.39	107.75	120.12	130.19	188.81	211.93	279.03	325.03	375.86	446.78	565.28
CEPS(Rs)	103.71	114.78	126.92	137.92	196.43	219.89	307.08	352.39	406.96	479.71	598.77
DPS(Rs)	23	31	35	40	55	65	250	275	275	325	410
Book NAV/Share(Rs)	370.77	441.2	562.65	646.43	786.76	932.19	1127.5	1203.71	1306.18	1480.48	1721.76
Core EBITDA Margin(%)	11.58	13.44	13.75	13.43	15.83	16.42	18.47	20.56	21.51	21.96	24.04
EBIT Margin(%)	12.76	14.88	15.14	14.92	18.91	19.06	19.82	21.12	21.86	23.5	26.97
Pre Tax Margin(%)	12.76	14.86	15.04	14.85	18.79	19	19.61	20.71	21.48	23.2	26.77
PAT Margin (%)	8.59	9.88	9.65	9.41	12.13	12.24	14.49	15.45	15.89	17.29	19.88
Cash Profit Margin (%)	9.54	10.53	10.19	9.97	12.62	12.7	15.94	16.75	17.2	18.57	21.05
ROA(%)	12.96	11.2	13.39	15.12	18.01	16.9	18.36	18.78	19.89	21.71	24.73
ROE(%)	27.66	26.54	23.93	21.54	26.35	24.66	27.09	27.89	29.95	32.07	35.31
ROCE(%)	41.07	39.98	37.55	33.96	40.61	37.88	36.54	37.52	40.53	42.93	47.34
Receivable days	19.78	18.77	18.91	19.95	24.26	26.77	26.49	23.19	19.54	20.18	19.26
Inventory Days	49.21	58.54	52.03	54.07	59.93	59.14	50.56	50.82	51.02	44.44	38.3
Payable days	33.37	45.79	51.74	75.01	91.74	99.97	104.13	108.42	113.47	109.28	107.36
PER(x)	18.77	36.64	39.19	35.63	28.86	34.43	55.39	46.11	47.09	49.43	47.67
Price/Book(x)	4.73	8.95	8.37	7.18	6.93	7.83	13.71	12.45	13.55	14.92	15.65
Dividend Yield(%)	1.31	0.79	0.74	0.86	1.01	0.89	1.62	1.83	1.55	1.47	1.52
EV/Net Sales(x)	1.43	3.38	3.5	3.02	3.2	3.76	7.49	6.83	7.1	8.41	9.43
EV/Core EBITDA(x)	10.3	21.53	22.08	19.27	16.44	19.25	35.19	29.37	29.93	33.09	32.4
Net Sales Growth(%)	37.71	0.59	14.2	11.02	13.64	11.52	11.27	5.3	14	8.86	9.35
EBIT Growth(%)	37.03	17.05	16.14	9.49	42.59	12.12	15.71	16.39	16.37	17.38	26.39
PAT Growth(%)	37.15	15.37	11.48	8.38	45.03	12.24	31.67	16.49	15.64	18.87	26.52
EPS Growth(%)	37.15	15.37	11.48	8.38	45.03	12.24	31.66	16.49	15.64	18.87	26.52
Debt/Equity(x)	0	0	0	0	0	0	0	0	0	0	0
Current Ratio(x)	2.06	1.99	3.79	3	3.34	3.22	3.6	3.38	3.2	2.51	2.42
Quick Ratio(x)	1.51	1.53	2.83	2.2	2.46	2.51	3	2.69	2.63	1.97	1.96
Interest Cover(x)	3532.82	685.07	158.63	215.33	163.6	311.82	95.1	51.65	57.53	80.66	130.94
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0	0

Abbott India Shareholding Pattern

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	74.99	74.99	74.99	74.99	74.99	74.99	74.99	74.99	74.99	74.99
FII	0.2	0.2	0.2	0.19	0.19	0.18	0.18	0.18	0.18	0.16
DII	7.95	7.86	8.39	8.62	8.78	8.83	8.74	8.91	8.81	9
Public	16.86	16.95	16.42	16.21	16.05	16	16.1	15.93	16.02	15.85
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoter	1.59	1.59	1.59	1.59	1.59	1.59	1.59	1.59	1.59	1.59
FII	0	0	0	0	0	0	0	0	0	0
DII	0.17	0.17	0.18	0.18	0.19	0.19	0.19	0.19	0.19	0.19
Public	0.36	0.36	0.35	0.34	0.34	0.34	0.34	0.34	0.34	0.34
Others	0	0	0	0	0	0	0	0	0	0
Total	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12	2.12

Pros

Company has delivered good profit growth of 21% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 32%
Debtor days have improved from 109.28 to 107.36days.
Company is almost debt free.

Cons

Stock is trading at 17.6 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Abbott India News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Abbott India

Add Watchlist

Abbott India Research see more...

Overview Inc. Year: 1944Industry: Pharmaceuticals & Drugs

Abbott India Share Price

Alert Data

Quarterly Price

Peer Comparison

Abbott India Quarterly Results

Abbott India Profit & Loss

Growth Rates

Abbott India Balance Sheet

Abbott India Cash Flow

Abbott India Ratios

Abbott India Shareholding Pattern

Abbott India News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!